Last Updated: June 22, 2026

DEXTROSE; POTASSIUM CHLORIDE; POTASSIUM LACTATE; SODIUM CHLORIDE; SODIUM PHOSPHATE, MONOBASIC ANHYDROUS - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for dextrose; potassium chloride; potassium lactate; sodium chloride; sodium phosphate, monobasic anhydrous and what is the scope of freedom to operate?

Dextrose; potassium chloride; potassium lactate; sodium chloride; sodium phosphate, monobasic anhydrous is the generic ingredient in one branded drug marketed by Hospira and is included in one NDA. Additional information is available in the individual branded drug profile pages.

Summary for DEXTROSE; POTASSIUM CHLORIDE; POTASSIUM LACTATE; SODIUM CHLORIDE; SODIUM PHOSPHATE, MONOBASIC ANHYDROUS

US Patents and Regulatory Information for DEXTROSE; POTASSIUM CHLORIDE; POTASSIUM LACTATE; SODIUM CHLORIDE; SODIUM PHOSPHATE, MONOBASIC ANHYDROUS

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira IONOSOL T AND DEXTROSE 5% IN PLASTIC CONTAINER dextrose; potassium chloride; potassium lactate; sodium chloride; sodium phosphate, monobasic anhydrous INJECTABLE;INJECTION 019514-001 May 8, 1986 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Market Dynamics and Financial Trajectory for Dextrose, Potassium Chloride, Potassium Lactate, Sodium Chloride, and Sodium Phosphate, Monobasic Anhydrous

Last updated: March 7, 2026

What Are the Market Drivers for These Electrolyte and Sugar Solutions?

The demand for dextrose, potassium chloride, potassium lactate, sodium chloride, and sodium phosphate monobasic anhydrous stems from multiple sectors, including clinical nutrition, pharmaceuticals, food processing, and industrial applications.

Key Market Drivers:

  • Growth in healthcare and hospital nutrition demand increases requirement for intravenous (IV) hydration solutions containing these compounds.
  • Expanded use of electrolyte salts to manage dehydration, electrolyte imbalance, and specific medical conditions.
  • Rising awareness of nutrient supplementation in sports nutrition and clinical settings.
  • Increasing food and beverage processing activities, where these ingredients function as preservatives, flavor enhancers, and pH stabilizers.
  • Industrial applications, notably in water treatment and chemical manufacturing.

Market Size and Revenue Projections

Global markets for these compounds exhibit varied growth trajectories, primarily driven by ongoing healthcare demands and food industry expansion.

Compound 2022 Market Value (USD Millions) 2027 Projected Value (USD Millions) CAGR (2022-2027)
Dextrose 2,045 2,600 4.9%
Potassium Chloride 850 1,100 5.1%
Potassium Lactate 320 400 4.4%
Sodium Chloride 4,200 4,600 1.8%
Sodium Phosphate, Monobasic Anhydrous 150 190 4.0%

Markets exhibit variance, with sodium chloride maintaining the largest share, driven by industrial and food sector demand. The fastest growth occurs in potassium chloride and potassium lactate, reflecting rising electrolyte replacement needs.

Cost Structures and Pricing Trends

Pricing varies by purity, grade (pharma, food, industrial), and region. Bulk procurement, manufacturing scale, and supply chain efficiencies influence margins.

  • Dextrose prices stabilized around USD 1,200–1,500 per metric ton in 2022.
  • Potassium chloride averages USD 1,000–1,300 per metric ton.
  • Sodium chloride priced between USD 200–400 per ton.
  • Sodium phosphate monobasic anhydrous ranges USD 1,500–1,800 per ton.
  • Potassium lactate fluctuates between USD 2,200 and 2,800 per ton.

Market trends indicate downward pressure on bulk prices due to increased production capacity, notably in Asia.

Competitive Landscape

Leading producers include:

  • BASF
  • OxyChem
  • Deepak Nitrite
  • Taj Pharmaceuticals
  • Merck KGaA

Regional players prioritize cost-efficient manufacturing, with Asia-Pacific emerging as a manufacturing hub for lower-cost bulk supplies.

Regulatory and Supply Chain Influences

Stringent pharmaceutical standards (e.g., USP, EP, JP) influence supply quality and manufacturing processes, particularly for pharma-grade substances.

Supply chain disruptions, notably during the COVID-19 pandemic, underscored reliance on Asian manufacturing and transport vulnerabilities, prompting diversification strategies.

Investment Opportunities and Risks

Investors should monitor:

  • Expansion of biopharmaceutical and clinical nutrition sectors.
  • Regulatory changes impacting manufacturing standards.
  • Potential shifts in raw material costs, especially for potassium and sodium salts.
  • Environmental regulations affecting manufacturing emissions.

Risks include supply chain dependencies, geopolitical tensions, and fluctuating raw material prices.

Key Takeaways

  • The global market for these electrolytes and sugars grows steadily, driven by healthcare, food, and industrial sectors.
  • Sodium chloride remains dominant but shows slow growth; electrolyte salts like potassium chloride and potassium lactate grow faster.
  • Price stability is influenced by supply chain dynamics and regional manufacturing capacity.
  • The competitive landscape favors Asian manufacturers due to cost advantages.
  • Regulatory standards remain a high compliance priority, influencing manufacturing and distribution.

FAQs

1. Which regions are the primary markets for these compounds?
North America and Europe dominate healthcare and pharmaceutical segments, while Asia-Pacific leads in industrial and food sector manufacturing.

2. What factors could disrupt supply chains?
Pandemic impacts, geopolitical tensions, and shipping constraints could cause shortages or price spikes.

3. Are there innovations affecting market growth?
Yes, advances in biopharmaceutical formulations and sustainable manufacturing processes influence demand.

4. How do regulatory standards impact pricing?
Strict compliance increases production costs, and non-compliance risks market access. Certifications differ across regions, impacting supply chains.

5. What is the outlook for new entrants?
Highly competitive markets with established players dominate; entry requires significant capital and regulatory expertise but benefits from regional manufacturing shifts and demand growth.


References

[1] Research and Markets. (2023). Electrolyte Salts Market Analysis.
[2] Grand View Research. (2022). Global Dextrose Market.
[3] U.S. Pharmacopeia. (2022). Standards for Active Pharmaceutical Ingredients.
[4] MarketWatch. (2023). Pricing trends for industrial chemicals.
[5] Asian Chemical Weekly. (2022). Manufacturing capacity expansion in Asia.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.